ℹ️ Document Conversion Notice: This document has been converted from PDF and formatted to fit this screen. Diagrams and images may be available only in the original here.

Roche Pharma Day 2022

London, 12 September 2022

Introduction

This document summarizes the key discussions and presentations from Roche Pharma Day 2022, held in London on September 12, 2022. The event provided an in-depth look at Roche's pharmaceutical strategy, its robust pipeline, growth drivers, and commercial opportunities across various therapeutic areas.

Presentations covered advancements in Oncology, Hematology, Neuroscience, Immunology, Infectious Diseases, and Ophthalmology, highlighting innovative research, clinical development progress, and the company's vision for addressing evolving healthcare needs. Key themes included the continuous increase in pipeline breadth and depth, digital strategy as an enabler, and a commitment to R&D as a driver of future growth.

For more information about Roche's pharmaceutical endeavors, please visit the official website: www.roche.com.

Google Docs
Google Drive
Download [pdf]

File Info : application/pdf, 127 Pages, 12.36MB

pharma-day-2022 09112022 final Microsoft PowerPoint 2016 Microsoft PowerPoint 2016

Related Documents

	Financial Support for Patient Organizations in North Macedonia A summary of financial and non-financial support provided to various patient organizations in North Macedonia, detailing the purpose and value of the support.
	Roche Diagnostics Showcases Innovation at ADLM 2025 \| Science-Driven Healthcare Solutions Roche Diagnostics highlights its latest innovations in diagnostics, including AI solutions, cardiovascular and cervical cancer screening advancements, and new platform technologies at ADLM 2025 in Chicago. Learn about their commitment to improving patient outcomes and healthcare delivery.
	Roche Honored with 2025 IMV ServiceTrak Clinical Laboratory Awards Roche receives seven 2025 IMV ServiceTrak awards for excellence in Customer Satisfaction, System Performance, and Service Performance across Clinical Chemistry, Integrated Workstation, and Immunoassay Systems.
	Decentralized Care: A Path to Better Efficiency and Outcomes in Healthcare This white paper explores the implementation of decentralized healthcare models based on the experiences of the UK, Singapore, the Netherlands, and Belgium. It details the key pillars of decentralized care: policy and regulation, technology and data, infrastructure and service delivery, and training. The document highlights the results, KPIs, and lessons learned from these countries in improving healthcare efficiency, patient access, and overall outcomes.
	Tecentriq (Atezolizumab) Prescribing Information and Clinical Use Comprehensive prescribing information for Tecentriq (atezolizumab), including therapeutic indications for various cancers like NSCLC, SCLC, TNBC, and HCC, dosage and administration guidelines, warnings, precautions, clinical trial data, and safety information.
	Richeal Cline Biography and Roche Diagnostics Overview Profile of Richeal Cline, Head of Diagnostics Global Operations and Global Head of Quality & Regulatory at Roche Diagnostics, along with an overview of Roche's leadership in healthcare.
	Roche Receives FDA Approval for VENTANA MET (SP44) RxDx Assay for Non-Small Cell Lung Cancer Roche announces FDA approval of the VENTANA MET (SP44) RxDx Assay, the first companion diagnostic to identify non-small cell lung cancer patients eligible for treatment with AbbVie's EMRELIS™.
	ACCU-CHEK ADVANTAGE CONTROL SOLUTION CA Safety Data Sheet Safety Data Sheet for ACCU-CHEK ADVANTAGE CONTROL SOLUTION CA, providing comprehensive information on product identification, hazard assessment, composition, first aid measures, firefighting, accidental release, handling and storage, exposure controls, physical and chemical properties, stability and reactivity, toxicological information, ecological information, disposal considerations, transport information, and regulatory information.